![1]()
News
Dapagliflozin in HFrEF may cut arrhythmias, sudden death: DAPA-HF
August 27, 2021
Response to the positive findings was tempered, however, by the post hoc nature of the analysis, choice of primary outcome, and inconsistencies between key subgroups.
![1]()
News
ICMs detect serious arrhythmias in high-risk post-MI patients: SMART-MI
August 27, 2021
In patients with modestly reduced left ventricular ejection fraction after MI, implantable monitors detect many times more arrhythmias than usual care, the SMART-MI trial showed.
News
U.S. plans COVID-19 booster shots at 6 months instead of 8: WSJ
August 27, 2021
Approval of boosters for three COVID-19 shots being administered in the United States is expected in mid-September.
![1]()
News
Optimizing screening for asymptomatic Afib
August 27, 2021
How can we optimize screening for patients with asymptomatic atrial fibrillation (Afib)?
![1]()
News
EMPEROR-Preserved: Empagliflozin scores HFpEF breakthrough
August 27, 2021
Empagliflozin is the first treatment to produce an unequivocal, hard-endpoint benefit in patients with heart failure with preserved ejection fraction, a practice-changing result.
![1]()
News
Genetic link may tie cannabis use disorder to severe COVID-19
August 27, 2021
“These data have important implications for policy regarding vaccination as well as treatment prioritization,” said lead author Dr. Alexander S. Hatoum.
![1]()
News
COVID-19: New GI symptoms don’t raise death risk in IBD
August 27, 2021
International registry data show new onset of GI symptoms is common in IBD patients with COVID-19 regardless of IBD disease status.
News
Time to positivity doesn’t predict mortality in bloodstream infections with enterococci
August 26, 2021
The researchers found no significant association between risk for death and time to positivity with bloodstream infections with E faecalis, VSEfm, or VREfm, or its cutoffs.
![1]()
News
ACE-I or ARB therapy in patients with low eGFR
August 26, 2021
Is it safe to continue angiotensin-converting enzyme inhibitor (ACE-I) or angiotensin II receptor blocker (ARB) therapy in patients whose estimated glomerular filtration rate (eGFR) has decreased to below 30 mL/min per 1.73 m2?
News
One-third in U.S. had been infected by SARS-CoV-2 through 2020: Study
August 26, 2021
“We have not turned the corner on COVID-19 and are nowhere near herd immunity – if it exists for SARS-CoV-2.”
